Cost analysis of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers in the context of diagnosis related groups (DRG) payment

This publication has 18 references indexed in Scilit:

• Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers at hospital admission to prevent hospital-acquired MRSA infections
  Clinical Microbiology & Infection, 2005
• Methicillin-resistantStaphylococcus aureusin Europe, 1999–2002
  Emerging Infectious Diseases, 2004
• Adverse Clinical and Economic Outcomes Attributable to Methicillin Resistance among Patients withStaphylococcus aureusSurgical Site Infection
  Clinical Infectious Diseases, 2003
• A systematic audit of economic evidence linking nosocomial infections and infection control interventions: 1990-2000
  American Journal of Infection Control, 2002
• The Economic Impact of Methicillin-Resistant Staphylococcus aureus in Canadian Hospitals
  Infection Control & Hospital Epidemiology, 2001
• Screening High-Risk Patients for Methicillin-ResistantStaphylococcus Aureuson Admission to the Hospital Is It Cost Effective?
  Infection Control & Hospital Epidemiology, 1999
• Nosocomial Methicillin-Resistant and Methicillin-SusceptibleStaphylococcus AureusPrimary Bacteremia: At What Costs?
  Infection Control & Hospital Epidemiology, 1999
• Selective Screening of Carriers for Control of Methicillin-Resistant Staphylococcus aureus (MRSA) in High-Risk Hospital Areas with a High Level of Endemic MRSA
  Clinical Infectious Diseases, 1998
• Selected Aspects of the Socioeconomic Impact of Nosocomial Infections: Morbidity, Mortality, Cost, and Prevention
  Infection Control & Hospital Epidemiology, 1996
• The Decline of Methicillin Resistance among Danish Staphylococcus aureus Strains
  Infection Control & Hospital Epidemiology, 1991